Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-07

Stereocontrolled synthesis of naturally occurring cladiellin oxacycles

Objective



Research objectives and content
The cladiellin and eunicellin oxacycles, together with eleutherobin, constitute a family of potential antitumour medium ring ether natural products. The research programme involves the following objectives: (i) Petasis methylenation of vinyl-substituted cyclic carbonates, followed by (3.3) sigmatropic rearrangement, to give medium ring lactones. (ii) Elaboration of 9-membered lactones to 2,9-divinyl substituted oxonins for ring closing methathesis to eleutherobin analogues.
(iii) Synthesis of a naturally occurring cladiellane by
intramolecular Diels-Alder cycloaddition of a 2,9-disubstituted oxonin. (iv) Evaluation of the synthetic materials as potential cytotoxic agents. This work programme will last 24 months.
Training content (objective, benefit and expected impact)
The objective of the programme is to acquire experience in multistep natural product synthesis in a stimulating research active environment. In addition to the development of new synthetic methodology and generation of cytotoxic compounds, the experience gained is expected to enable the applicant to continue with an independent academic career.
Links with industry / industrial relevance (22)
Glaxo-Wellcome and Smithkline Bechham pharmaceuticals have an active interest in the research programme and will evaluate materials.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

University of Cambridge
EU contribution
No data
Address
Lensfield Road
CB2 1EW Cambridge
United Kingdom
Total cost
No data